Heart failure resulting from myocardial infarction (MI) remains a leading cause of global mortality, despite recent advancements in its treatment. Current therapeutic approaches aim to stabilize scars, reduce infarct expansion, and mitigate ventricular wall stress to improve patient outcomes. Cardiac tissue engineering (CTE) offers a promising strategy for repairing and regenerating damaged myocardium post-MI. Biological scaffolds play a pivotal role in CTE by mimicking native tissue environment, facilitating cell adhesion, alignment, and organization into functional cardiac patches. However, traditional scaffolds often fail to replicate the unique mechanical properties of the myocardium, such as its negative Poisson's ratio, critical for withstanding daily mechanical demands.